Veriheal

JANUARY 28, 2022

Despite Social Media Buzz, Researchers Say CBD COVID Cure Not Yet a Reality. Lost in the media frenzy, however, was the fact that this finding wasn’t an end-all-be-all. Rather, it was only an indication that CBD’s ability to fight COVID-19 warranted further research under more rigorous clinical trials.

Dispensary 98

Dispensary Clinical Trials CBD Legalization 98

Cannabis Law Report

DECEMBER 27, 2019

Virtual Clinical Trials transcend geographic, mobility and economic barriers. Clinical trials are medical research projects involving human participants. However, the costs of conducting a full-scale clinical trial can be prohibitive, posing barriers to research for cannabis companies.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Cannabis Law Report

AUGUST 3, 2021

state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. Securities Act and applicable state securities laws. Except as required by law, the Company does not intend to update these forward-looking statements. Media Contact : John Kanakis. About Cybin.

Clinical Trials 105

Clinical Trials Events Treatment Banking 105

Cannabis Law Report

APRIL 21, 2022

The availability of larger quantities of cGMP-compliant MDMA will facilitate ongoing clinical trials and provide for future therapeutic use following anticipated regulatory approvals. in each of the four validation trials with an acceptable yield, which is a noteworthy accomplishment. MEDIA CONTACT . 831-429-6362 ext 303.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Cannabis Law Report

NOVEMBER 23, 2021

COMP360 has been designated a Breakthrough Therapy by the US Food and Drug Administration (FDA), for treatment-resistant depression (TRD), and we have completed a phase IIb clinical trial of psilocybin therapy for TRD, in 22 sites across Europe and North America.

Clinical Trials 52

Clinical Trials Therapy Research and Development Media 52

Cannabis Law Report

JULY 8, 2021

Forward-Looking Statements This press release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. Media Contacts Caitlin Kasunich / Raquel Cona KCSA Strategic Communications 212.896.1241 / 212.896.1204 ckasunich@kcsa.com / rcona@kcsa.com.

Treatment 98

Treatment Clinical Trials CBD Patients 98

Cannabis Law Report

FEBRUARY 28, 2022

Clinical trials are producing promising results, creating enthusiasm for commercializing and patenting psychedelics. 1025, 1026 (2021) (reporting significant improvement of PTSD symptoms following treatment with MDMA in clinical trial); see also Alec J. Mitchell et al., Divito & Robert F. 11 × 11. 15 × 15.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

AUGUST 12, 2021

Phase IIb clinical trial of COMP360 psilocybin therapy for TRD close to completion. As a result, we encourage investors, the media, and others interested in us to review the information that is posted on these channels, including the investor relations website, on a regular basis. Business highlights.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

DECEMBER 9, 2021

Certain statements in this news release related to the Company constitute “forward-looking information” within the meaning of applicable securities laws and are prospective in nature. Except as required by law, the Company does not intend and does not assume any obligation to update this forward-looking information.

Research and Development 52

Research and Development Clinical Trials Therapy Medicine 52

Cannabis Law Report

JUNE 30, 2021

LONDON–(BUSINESS WIRE)– Fourfive , the CBD and nutrition brand loved by athletes and those leading an active lifestyle, today called on the UK’s sports governing bodies to stop sitting if on the fence and conduct clinical trials into the effectiveness of CBD and medicinal cannabis in professional sport. fourfive.com.

Medicine 75

Medicine Clinical Trials CBD Sleep 75

Cannabis Law Report

JULY 24, 2021

The groundbreaking progress that we’ve seen from the Multidisciplinary Association for Psychedelic Studies (MAPS) in its Phase 3 clinical trials of MDMA-assisted psychotherapy for Post-Traumatic Stress Disorder (PTSD), including receiving Breakthrough Therapy Designation from the Food and Drug Administration (FDA), shows great promise to date.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Cannabis Law Report

JUNE 30, 2021

In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials. CannabisFN.com and CFN Media, have been hired to create awareness. Mental Health Challenges. Psychedelics Provide a Solution.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Cannabis Law Report

AUGUST 16, 2021

–(BUSINESS WIRE)–Celebrity blogger and media personality Perez Hilton and leading hemp-based CBD researchers have forged a business partnership in support of My True 10 , a CBD Gummies line available at mytrue10.com Perez Hilton’s Personal Wellness Journey Encourages & Supports Others to Live Well. CARSON CITY, Nev.–(BUSINESS

Food 105

Food CBD Research and Development Clinical Trials 105

Veriheal

JULY 16, 2020

Despite the novelty of its drug policy findings, the document has gone largely unnoticed by reform advocates and the media. federal government’s policies have blocked externally valid, randomized clinical trials on the effects of cannabis,” the report says. Veterans across the U.S.

Research and Development 95

Research and Development Clinical Trials Treatment Compliance 95

Cannabis Law Report

JANUARY 12, 2022

“We can now concentrate all our energies on advancing our plant-inspired, biopharmaceutical research and development programs into human clinical trials.” Media Contact. Andrea Small-Howard, President and Chief Science Officer of Gb Sciences. 31, 2021. Savannah Muir. savannah@newswire.com.

Research and Development 52

Research and Development Clinical Trials Chronic Pain Therapy 52

Cannabis Law Report

NOVEMBER 22, 2019

“As MMJ International Holdings continues to advance to its clinical trials, a specialty pharmaceutical solutions company will be supporting MMJ with the FDA, DEA required development API and specialized liquid encapsulation solutions,” said Elio Mariani, PhD, EVP of Research & Development. 561-627-9455. 917-562-9610.

DEA 66

DEA Clinical Trials THC Research and Development 66

Cannabis Law Report

DECEMBER 8, 2021

Charles River Laboratories, a renowned CRO engaged by Virpax to perform Food and Drug Administration (FDA) required pre-clinical studies, has completed a single dose pharmacokinetic study of dermal administration of Epoladerm in minipigs as part of the required Investigational New Drug Application (“IND”) enabling trials.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Topical 52

Cannabis Law Report

OCTOBER 22, 2021

SPL026 entered clinical trials at the beginning of 2021 and this designation marks an important step forward towards an accelerated drug approval pathway for bringing the benefits of SPL026 to market for patients suffering with MDD.”. Media Relations Contact. For further information contact: . Small Pharma Inc. Peter Rands.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

Cannabis Law Report

JULY 23, 2019

Businesses preparing to market a new product nationally must follow the rules of trademark law as well as marketing and advertising claims under state and US laws when creating a trademark, advertising copy and copyright-registered packaging for the product. Laws on Legalised Cannabis.

Law 40

Law Clinical Trials CBD Edibles 40

Cannabis Law Report

OCTOBER 5, 2021

Media: media@mymd.com. Forward-looking statements speak only as of the date they are made and MyMD disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future events or otherwise. Investor: Robert Schatz. 646) 421-9523. rschatz@mymd.com www.mymd.com.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Media 52

Cannabis Law Report

FEBRUARY 10, 2022

A look at key research and clinical trials that were published in 2021, with analysis of themes like microdosing and SSRI interactions. There’s no two ways about it: this is a text-heavy long-read: apologies in advance for those that prefer their media diet to be a little more visual. and Canada. Access the PDF here.

Clinical Trials 52

Clinical Trials Microdosing Pharmaceutical Policy 52

Cannabis Law Report

JANUARY 11, 2019

federal law protects the retail sale of hemp-derived CBD. . Our analysis follows: Hemp-derived CBD is no longer a controlled substance under federal law. The FDA’s position on CBD is unsettled and unsupported by law. While the DEA is now officially out of the hemp regulation business, the U.S.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

Cannabis Law Report

JULY 9, 2021

federal law, despite this prohibition, a limited number of states have either sought to decriminalize or authorize the medical use of certain psychedelic drugs and substances in limited circumstances. where applicable laws permit such activities. federal law. SOURCE Horizons ETFs Management ( Canada ) Inc. Related Links.

Data 105

Data Clinical Trials Decriminalization Hemp 105

Cannabis Law Report

OCTOBER 15, 2021

At Kidney Week 2021, Goldfinch Bio will present multiple e-posters, including: The design of TRACTION-2, the ongoing Phase 2 clinical trial evaluating GFB-887 for the treatment of focal segmental glomerulosclerosis (FSGS) and diabetic nephropathy (DN). Media: Liz Melone. Visit us at www.goldfinchbio.com to learn more.

Clinical Trials 52

Clinical Trials Research and Development Data Patients 52

NORML

SEPTEMBER 20, 2019

We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses. Essentially, the federal government has monopolized cannabis research, and ElSohly’s product, according to some scientists who’ve seen it, is unsuitable for clinical trials.

DEA 227

DEA Research and Development Clinical Trials Patients 227

Cannabis Law Report

JUNE 7, 2021

Media Contact: Will Johnson. Forward-looking statements speak only as of the date they are made and MyMD disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future events or otherwise. Investor Contact: Brett Maas. 646-536-7331. brett@haydenir.com www.haydenir.com.

Pharmaceutical 79

Pharmaceutical Clinical Trials CBD Banking 79

Cannabis Law Report

FEBRUARY 28, 2020

It took twelve months of research, investigations and interviews (and about five weeks of non-stop writing with some very late nights and a lot of coffee) to produce my book on cannabis law and regulation, which is out now with Bloomsbury Professional. The story is remarkably different at domestic level.

Law 59

Law Research and Development Recreational Cannabis 59

MMJ Recs

DECEMBER 22, 2023

The early 2000s marked a turning point with the passage of medical marijuana laws in states like California, followed by a domino effect as other states recognized the potential therapeutic value of cannabis. Media outlets, social platforms, and public forums contribute to the ongoing discourse by presenting a spectrum of opinions.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. Media coverage of the paper led to a new stigma and political pressure ended the Spain MDMA study. Rick Doblin, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

JULY 6, 2021

Professor Johnson also received national media attention for his appearance in the Home Box Office (HBO) original documentary feature, “Addiction”, which won the prestigious Governors Award, a special Emmy Award, from the Academy of Television Arts and Sciences. ” About Ehave, Inc. Ehave, Inc.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

Cannabis Law Report

AUGUST 21, 2019

PUBLISHER: CANNABIS LAW REPORT. In November 2018, the legal status of cannabis was changed to allow specialist clinicians to legally prescribe cannabis-derived medicinal products to patients with an exceptional clinical need, following a high-profile media campaign. AUTHOR: Mark Taylor.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

Cannabis Law Report

DECEMBER 26, 2021

EBRX-101 on Track to Submit Regulatory Package for Human DMT Clinical Trial. The Company is pleased to confirm that it is on track to submit its regulatory package to the Dutch ethics committee in early 2022 for its upcoming human trial. For more information, please contact the Company at: Entheon Biomedical Corp.

Research and Development 52

Research and Development Clinical Trials Treatment Packaging 52

Cannabis Law Report

SEPTEMBER 22, 2021

Supera-CBD is currently on a path toward human clinical trials as a therapy for epilepsy, followed by chronic pain. Media Contact: media@mymd.com. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc. Investor Contact: Robert Schatz. 646) 421-9523. rschatz@mymd.com www.mymd.com.

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Cannabis Law Report

JANUARY 6, 2022

Scott will work closely with the management team to further develop the company’s internal and external communications with a focus on strategy, branding, social media presence and investor communications. Anebulo Pharmaceuticals, Inc. Scott Anderson.

Pharmaceutical 52

Pharmaceutical Clinical Trials Cannabinoids Programs 52

Cannabis Law Report

DECEMBER 9, 2021

MAPS is sponsoring the most advanced psychedelic therapy research in the world: Phase 3 clinical trials of MDMA-assisted therapy for PTSD. Media Contact nuelife@derris.com. For more information, please visit www.nue.life. SOURCE Nue Life Health.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

Cannabis Law Report

MARCH 29, 2020

among human subjects, legal knowledge of the laws outlined the Cannabis Act should be distributed to all participants ahead of time. With cannabis, every user has a different experience, but the law that applies to everyone is the same. Respondent experience must be central to the research exercise.

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

Cannabis Law Report

SEPTEMBER 20, 2021

KWC is a limited liability corporation formed under the laws of Arizona , which operates 10 ketamine infusion treatment clinics, across Arizona , Colorado , Florida , Illinois , Minnesota , Nevada , Texas , and Washington. Transaction Highlights.

Treatment 52

Treatment Media Research and Development Patients 52